![Mark Oki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Oki
Direttore Finanziario/CFO presso
NEOS THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/08/2026
Profilo
Mark K.
Oki is currently Chief Financial Officer at Neos Therapeutics, Inc. and Chief Financial Officer at Achieve Life Sciences, Inc. Formerly, Mr. Oki was Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. from 2022 to 2024; Chief Financial & Accounting Officer at VIVUS, Inc. from 2015 to 2019; CFO, Secretary & Senior VP-Finance at Alexza Pharmaceuticals, Inc. in 2015; Controller at Pharmacyclics LLC in 2006; and Assistant Controller at Incyte Corp.
from 1998 to 2001.
Education includes an undergraduate degree from San Jose State University conferred in 1991.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/01/2026 | 127.940 ( 0,12% ) | 1 M $ | 31/08/2026 |
Posizioni attive di Mark Oki
| Società | Posizione | Inizio |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Direttore Finanziario/CFO | - |
| ACHIEVE LIFE SCIENCES, INC. | Direttore Finanziario/CFO | 05/12/2024 |
Precedenti posizioni note di Mark Oki
| Società | Posizione | Fine |
|---|---|---|
| AYTU BIOPHARMA, INC. | Direttore Finanziario/CFO | 11/11/2024 |
| ALEXZA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 16/10/2015 |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 01/04/2006 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/01/2001 |
| VIVUS, INC. | Direttore Finanziario/CFO | - |
Formazione di Mark Oki
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
